Dermal Progression of Neonatal Jaundice of Newborn Under 35 Weeks of Gestational Age
Aim:To determine the dermal progression of neonatal jaundice in newborns under 35 weeks of gestational age and those risk factors which affect dermal progression.Materials and Methods:We prospectively enrolled eighty-eight preterm newborns under 35 weeks of gestational age in neonatol intensive care...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayinevi
2022-12-01
|
Series: | Journal of Pediatric Research |
Subjects: | |
Online Access: |
http://jpedres.org/archives/archive-detail/article-preview/dermal-progression-of-neonatal-jaundice-of-newborn/57509
|
_version_ | 1797910338281144320 |
---|---|
author | Çisil Çerçi Kubur Burçin İşcan Nuray Duman Hasan Özkan Abdullah Kumral |
author_facet | Çisil Çerçi Kubur Burçin İşcan Nuray Duman Hasan Özkan Abdullah Kumral |
author_sort | Çisil Çerçi Kubur |
collection | DOAJ |
description | Aim:To determine the dermal progression of neonatal jaundice in newborns under 35 weeks of gestational age and those risk factors which affect dermal progression.Materials and Methods:We prospectively enrolled eighty-eight preterm newborns under 35 weeks of gestational age in neonatol intensive care unit of Dokuz Eylül University Hospital. It was a cross-sectional analytic case study. We measured capillary and transcutaneous bilirubin levels. Multiple sites of TcB measurement were performed.Results:We observed that there is no significant difference between capillary and transcutaneous bilirubin measurements on preterm newborns under 35 weeks of gestational age (pearson’s rho >75 and p<0.05). Additionally, we also observed that transcutaneous bilirubin measurements on preterm newborns under 35 weeks of gestational age (the first day taken on the back, the fourth day on the forehead and the remaining days on the chest) are higher than on the other sides (Friedman test). Therefore, for preterm newborns, jaundice progresses in a different way to cephalocaudal direction with progressive hyperbilirubinemia. We did not observe any association between the existence of cephalocaudal progression in preterm newborns and the laboratory data associated with the mother and baby (Mann-Whitney U test, p>0.05).Conclusion:Transcutaneous bilirubin measurements can be used for neonatal jaundice of newborns under 35 weeks of gestational age. However, we need further studies for comprehensive descriptions of preterm newborns’ jaundice progression. |
first_indexed | 2024-04-10T11:22:52Z |
format | Article |
id | doaj.art-f6f12640fdf54dc499e38be84b8ecfd2 |
institution | Directory Open Access Journal |
issn | 2147-9445 2587-2478 |
language | English |
last_indexed | 2024-04-10T11:22:52Z |
publishDate | 2022-12-01 |
publisher | Galenos Yayinevi |
record_format | Article |
series | Journal of Pediatric Research |
spelling | doaj.art-f6f12640fdf54dc499e38be84b8ecfd22023-02-15T16:18:32ZengGalenos YayineviJournal of Pediatric Research2147-94452587-24782022-12-019433834410.4274/jpr.galenos.2022.5665013049054Dermal Progression of Neonatal Jaundice of Newborn Under 35 Weeks of Gestational AgeÇisil Çerçi Kubur0Burçin İşcan1Nuray Duman2Hasan Özkan3Abdullah Kumral4 Dokuz Eylül University Faculty of Medicine, Department of Pediatrics, İzmir, Turkey Dokuz Eylül University Faculty of Medicine, Department of Pediatrics, Division of Neonatology, İzmir, Turkey Dokuz Eylül University Faculty of Medicine, Department of Pediatrics, Division of Neonatology, İzmir, Turkey Dokuz Eylül University Faculty of Medicine, Department of Pediatrics, Division of Neonatology, İzmir, Turkey Dokuz Eylül University Faculty of Medicine, Department of Pediatrics, Division of Neonatology, İzmir, Turkey Aim:To determine the dermal progression of neonatal jaundice in newborns under 35 weeks of gestational age and those risk factors which affect dermal progression.Materials and Methods:We prospectively enrolled eighty-eight preterm newborns under 35 weeks of gestational age in neonatol intensive care unit of Dokuz Eylül University Hospital. It was a cross-sectional analytic case study. We measured capillary and transcutaneous bilirubin levels. Multiple sites of TcB measurement were performed.Results:We observed that there is no significant difference between capillary and transcutaneous bilirubin measurements on preterm newborns under 35 weeks of gestational age (pearson’s rho >75 and p<0.05). Additionally, we also observed that transcutaneous bilirubin measurements on preterm newborns under 35 weeks of gestational age (the first day taken on the back, the fourth day on the forehead and the remaining days on the chest) are higher than on the other sides (Friedman test). Therefore, for preterm newborns, jaundice progresses in a different way to cephalocaudal direction with progressive hyperbilirubinemia. We did not observe any association between the existence of cephalocaudal progression in preterm newborns and the laboratory data associated with the mother and baby (Mann-Whitney U test, p>0.05).Conclusion:Transcutaneous bilirubin measurements can be used for neonatal jaundice of newborns under 35 weeks of gestational age. However, we need further studies for comprehensive descriptions of preterm newborns’ jaundice progression. http://jpedres.org/archives/archive-detail/article-preview/dermal-progression-of-neonatal-jaundice-of-newborn/57509 dermal progressionneonatal jaundicegestational agetranscutaneous bilirubin measurementscephalocaudal progression |
spellingShingle | Çisil Çerçi Kubur Burçin İşcan Nuray Duman Hasan Özkan Abdullah Kumral Dermal Progression of Neonatal Jaundice of Newborn Under 35 Weeks of Gestational Age Journal of Pediatric Research dermal progression neonatal jaundice gestational age transcutaneous bilirubin measurements cephalocaudal progression |
title | Dermal Progression of Neonatal Jaundice of Newborn Under 35 Weeks of Gestational Age |
title_full | Dermal Progression of Neonatal Jaundice of Newborn Under 35 Weeks of Gestational Age |
title_fullStr | Dermal Progression of Neonatal Jaundice of Newborn Under 35 Weeks of Gestational Age |
title_full_unstemmed | Dermal Progression of Neonatal Jaundice of Newborn Under 35 Weeks of Gestational Age |
title_short | Dermal Progression of Neonatal Jaundice of Newborn Under 35 Weeks of Gestational Age |
title_sort | dermal progression of neonatal jaundice of newborn under 35 weeks of gestational age |
topic | dermal progression neonatal jaundice gestational age transcutaneous bilirubin measurements cephalocaudal progression |
url |
http://jpedres.org/archives/archive-detail/article-preview/dermal-progression-of-neonatal-jaundice-of-newborn/57509
|
work_keys_str_mv | AT cisilcercikubur dermalprogressionofneonataljaundiceofnewbornunder35weeksofgestationalage AT burciniscan dermalprogressionofneonataljaundiceofnewbornunder35weeksofgestationalage AT nurayduman dermalprogressionofneonataljaundiceofnewbornunder35weeksofgestationalage AT hasanozkan dermalprogressionofneonataljaundiceofnewbornunder35weeksofgestationalage AT abdullahkumral dermalprogressionofneonataljaundiceofnewbornunder35weeksofgestationalage |